Hudson Reddon1,2, Kora DeBeck1,3, Maria Eugenia Socias1,4, Huiru Dong1, Evan Wood1,4, Julio Montaner1,4, Thomas Kerr1,4, Michael-John Milloy1,4. 1. British Columbia Centre for Excellence in HIV/AIDS, Urban Health Research Initiative, St. Paul's Hospital, Vancouver, Canada. 2. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada. 3. School of Public Policy, Simon Fraser University, Vancouver, Canada. 4. Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, Canada.
Abstract
INTRODUCTION AND AIMS: Street-involved youth are known to be at elevated risk of initiating injection drug use. However, the impact of so-called 'gateway' drugs, such as cannabis, on injection initiation is unknown. The objective of this study was to examine the association between cannabis use and initiation of injection drug use among a prospective cohort of street-involved youth in Vancouver, Canada. DESIGN AND METHODS: Data for this study were collected from the At-Risk Youth Study. From September 2005 to May 2015, participants aged 14-26 who reported illicit drug use were recruited into this open prospective cohort study. An extended Cox regression model with time-updated covariates was used to identify factors independently associated with injection initiation. RESULTS: During the study period, 481 street-involved youth were included in this study. Of these, 228 (47.4%) reported at least daily cannabis use, and 103 (21.4%) initiated injection drug use. In a multivariable analysis, ≥daily cannabis use was associated with slower rates of injection initiation (adjusted relative hazard 0.66, 95% confidence interval 0.45-0.98; P = 0.038). Sub-analyses revealed that cannabis use was negatively associated with initiation of injection stimulants but not initiation of injection opioids. DISCUSSION AND CONCLUSIONS: Given the expansion of cannabis legalisation throughout North America, it is encouraging that cannabis use was associated with slower time to initiation of injection drug use in this cohort. This finding challenges the view of cannabis as a gateway substance that precipitates the progression to using harder and more addictive drugs.
INTRODUCTION AND AIMS: Street-involved youth are known to be at elevated risk of initiating injection drug use. However, the impact of so-called 'gateway' drugs, such as cannabis, on injection initiation is unknown. The objective of this study was to examine the association between cannabis use and initiation of injection drug use among a prospective cohort of street-involved youth in Vancouver, Canada. DESIGN AND METHODS: Data for this study were collected from the At-Risk Youth Study. From September 2005 to May 2015, participants aged 14-26 who reported illicit drug use were recruited into this open prospective cohort study. An extended Cox regression model with time-updated covariates was used to identify factors independently associated with injection initiation. RESULTS: During the study period, 481 street-involved youth were included in this study. Of these, 228 (47.4%) reported at least daily cannabis use, and 103 (21.4%) initiated injection drug use. In a multivariable analysis, ≥daily cannabis use was associated with slower rates of injection initiation (adjusted relative hazard 0.66, 95% confidence interval 0.45-0.98; P = 0.038). Sub-analyses revealed that cannabis use was negatively associated with initiation of injection stimulants but not initiation of injection opioids. DISCUSSION AND CONCLUSIONS: Given the expansion of cannabis legalisation throughout North America, it is encouraging that cannabis use was associated with slower time to initiation of injection drug use in this cohort. This finding challenges the view of cannabis as a gateway substance that precipitates the progression to using harder and more addictive drugs.
Authors: Brandon D L Marshall; Thomas Kerr; Jiezhi Qi; Julio S G Montaner; Evan Wood Journal: Drug Alcohol Depend Date: 2010-04-24 Impact factor: 4.492
Authors: Kora Debeck; Thomas Kerr; Brandon D L Marshall; Annick Simo; Julio Montaner; Evan Wood Journal: Drug Alcohol Depend Date: 2013-07-30 Impact factor: 4.492
Authors: Benedikt Fischer; Sharan Kuganesan; Andrea Gallassi; Renato Malcher-Lopes; Wim van den Brink; Evan Wood Journal: Int J Drug Policy Date: 2015-09-25
Authors: Scott E Hadland; Dan Werb; Thomas Kerr; Eric Fu; Hong Wang; Julio S Montaner; Evan Wood Journal: Prev Med Date: 2012-08-28 Impact factor: 4.018
Authors: Hudson Reddon; Kora DeBeck; M Eugenia Socias; Stephanie Lake; Huiru Dong; Mohammad Karamouzian; Kanna Hayashi; Thomas Kerr; M-J Milloy Journal: Am J Public Health Date: 2020-08-20 Impact factor: 9.308
Authors: Rachel Carmen Ceasar; Alex H Kral; Kelsey Simpson; Lynn Wenger; Jesse L Goldshear; Ricky N Bluthenthal Journal: Drug Alcohol Depend Date: 2020-11-23 Impact factor: 4.492
Authors: Johannes Thrul; Jill A Rabinowitz; Beth A Reboussin; Brion S Maher; Nicholas S Ialongo Journal: Addiction Date: 2020-07-21 Impact factor: 6.526